Page 18
Hospital Professional News, a leading specialist publishing agency with over 9 years of experience, is proud to announce the launch of the Hospital Professional Honours 2024. This prestigious…
Introduction: Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of malignant plasma cells in the bone marrow. MM manifests clinically as hypercalcaemia, renal failure,…
In October 2023, the 16th European Nursing of Oncology Society’s Conference (EONS16), ‘Cancer nursing: Building on innovation and building back better in healthcare’ took place in Madrid. The…
Pancreatic Cancer: A Tough Nut to Crack! Pancreatic cancer presents a significant clinical challenge. Currently, the 5-year survival rate for patients diagnosed with this cancer is only 12%,…
Introduction to Homologous Recombination Deficiency Homologous recombination deficiency (HRD) represents a pivotal concept in oncology, characterized by a functional loss in the homologous recombination repair (HRR) pathway. Essential…
Currently there are over 200,000 people living with and beyond cancer in Ireland and that number is expected to double over the next 25 years. Approximately 10% of…
Prof Seamus O’Reilly BSc MD PhD FRCPI is Consultant Medical Oncologist at Cork-Mercy and South Infirmary Victoria University Hospitals, Clinical Lead at Cancer Trials Ireland, and Clinical Professor…
Key partnerships enable charity (SII) to continue supporting 2,300+ individuals and families living with spinal cord injury across Ireland Spinal Injuries Ireland (SII), the country’s sole charitable organisation…
BioInnovate Ireland, the specialist medical device and health technology innovation programme at University of Galway, has launched its latest search for future healthcare innovators. The programme, which is formally affiliated to…
Pictured: Fiona Dunphy (PMI), Kerry McLaverty, CEO of LauraLynn and Fiona Dunphy (PMI)
You’re all caught up.
